Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

High-SPF Test Standards Possible Following Modifications - FDA

This article was originally published in The Tan Sheet

Executive Summary

FDA may consider a standardized sunscreen testing method for higher-SPF products if sufficient additional information is provided and found acceptable, the agency said at a working group meeting with industry in Rockville, Md. Oct. 26.

You may also be interested in...



Additional High SPF Sunscreen Data Sought By FDA

FDA expects to publish a "comprehensive" sunscreen final monograph covering formulation, labeling and testing methodologies for both UVA and UVB radiation by Dec. 31, 2001, the agency announces in a June 8 Federal Register notice.

High SPF "Uses" Statement Addresses FDA Concerns - CTFA

Sunscreens with SPF values over 30 should carry a mandatory labeling statement that advises consumers against extending the length of time spent in the sun while noting the benefits of additional sun protection, the Cosmetic Toiletry & Fragrance Association says in comments recently made available by FDA.

Additional High SPF Sunscreen Data Sought By FDA

FDA expects to publish a "comprehensive" sunscreen final monograph covering formulation, labeling and testing methodologies for both UVA and UVB radiation by Dec. 31, 2001, the agency announces in a June 8 Federal Register notice.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090504

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel